SCHEMBL3702408

SCHEMBL3702408

O=C(O)Nc1ccc(N2CCC[C@]3(CCN([C@H]4CC[C@H](O)CC4)C3=O)C2)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY2R P49146 7/20 0.41
KDM4E B2RXH2 1/20 0.40
RECQL P46063 1/20 0.40
ALDH1A1 P00352 6/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
PDE7A Q13946 1/20 0.39
HSD11B1 P28845 1/20 0.38
NPC1 O15118 5/20 0.37
MAPT P10636 5/20 0.37
RAB9A P51151 5/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
MAPK1 P28482 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
GRM4 Q14833 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2700128 1.00 NPY2R (0.41) NPY2RKDM4ERECQLALDH1A1HPGD
SCHEMBL2700122 1.00 NPY2R (0.41) NPY2RKDM4ERECQLALDH1A1HPGD
SCHEMBL3702412 1.00 NPY2R (0.41) NPY2RKDM4ERECQLALDH1A1HPGD
SCHEMBL3699636 0.90 PDE7A (0.39) NPY2RKDM4EALDH1A1PDE7AHSD11B1
SCHEMBL2697412 0.90 PDE7A (0.39) NPY2RKDM4EALDH1A1PDE7AHSD11B1
SCHEMBL2697416 0.90 PDE7A (0.39) NPY2RKDM4EALDH1A1PDE7AHSD11B1
SCHEMBL3699640 0.90 PDE7A (0.39) NPY2RKDM4EALDH1A1PDE7AHSD11B1
SCHEMBL2699857 0.90 HPGD (0.52) NPY2RKDM4ERECQLALDH1A1HPGD
SCHEMBL2699858 0.90 HPGD (0.52) NPY2RKDM4ERECQLALDH1A1HPGD
SCHEMBL551136 0.90 HPGD (0.52) NPY2RKDM4ERECQLALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8563570-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2013-10-22 US claimed
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2012-05-17 US claimed
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2009-11-26 US claimed
US-8563570-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2013-10-22 US disclosed
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2012-05-17 US disclosed
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2012-05-17 US disclosed
US-8110581-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2012-02-07 US disclosed
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2009-11-26 US disclosed
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS HSD11B1, HSD11B2, HSD17B1 NPY2R 2490/4885KDM4E 3021/4885RECQL 3329/4885
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS HSD11B1, HSD11B2, HSD17B1 NPY2R 2490/4885KDM4E 3021/4885RECQL 3329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.